Korea Republic Of to India: Pembrolizumab Import Trade Route
India has recorded 1 verified shipments of Pembrolizumab imported from Korea Republic Of, representing a combined trade value of $39.7K USD. This corridor is served by 1 active Korea Republic Of exporters, with an average shipment value of $39.7K USD. The leading Korea Republic Of supplier is NUVISAN FRANCE SARL, which accounts for 100% of total import value with 1 shipments worth $39.7K USD. On the buying side, FORTREA DEVELOPMENT INDIA PRIVATE LIMITED is the largest Indian importer with $39.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The Korea Republic Of to India Pembrolizumab corridor is one of India's established pharmaceutical import routes from Korea Republic Of, with 1 shipments documented worth a combined $39.7K USD. The route is dominated by NUVISAN FRANCE SARL, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Korea Republic Of's pembrolizumab export sector.
Across 1 active Korea Republic Of suppliers, the average shipment value stands at $39.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with pembrolizumab's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 29.3%, placing it at rank #18 among India's top pembrolizumab import origins globally.
On the Indian buyer side, key Indian importers include FORTREA DEVELOPMENT INDIA PRIVATE LIMITED. FORTREA DEVELOPMENT INDIA PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $39.7K USD.
Route Characteristics
- Average transit
